Related Experiment Video

Updated: Jun 13, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

2009 Pandemic influenza H1N1: paediatric perspectives

Hao Yuan Lee1, Chang Teng Wu, Tzou Yien Lin

  • 1Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Annals of the Academy of Medicine, Singapore
|May 18, 2010
PubMed

Insights

Children under 5 and those with chronic health issues face higher risks of severe pandemic H1N1 infection. This review details medical conditions linked to H1N1 complications and death in pediatric populations.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Pandemic H1N1 influenza posed a significant global health threat.
  • Certain pediatric populations exhibited increased vulnerability to severe outcomes.
  • Understanding risk factors is crucial for targeted interventions and prevention strategies.

Purpose of the Study:

  • To identify and review underlying medical conditions associated with severe pandemic H1N1 infection in children.
  • To highlight specific risk factors contributing to H1N1-related complications and mortality in pediatric patients.
  • To inform clinical practice and public health responses concerning H1N1 in children.

Main Methods:

  • Literature review of studies focusing on pandemic H1N1 infection in children.
  • Analysis of case reports and epidemiological data identifying risk factors for severe outcomes.
  • Synthesis of information on pre-existing conditions linked to H1N1 complications.

Main Results:

  • Children younger than 5 years are at increased risk.
  • Chronic medical conditions including respiratory diseases, neurological disorders, immunosuppression, obesity, and long-term aspirin therapy elevate risk.
  • Bacterial co-infections significantly increase the likelihood of severe H1N1 complications.

Conclusions:

  • Specific pediatric groups, particularly those with chronic illnesses, require vigilant monitoring during H1N1 outbreaks.
  • Early identification and management of risk factors can mitigate severe H1N1 outcomes in children.
  • Public health strategies should prioritize vaccination and supportive care for high-risk pediatric populations.

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...